Lv1
60 积分 2022-02-09 加入
[The Chinese expert consensus on hematopoietic stem cell transplantation for malignant lymphoma(2018)]
3天前
已完结
Matching-Adjusted Indirect Comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-Cell lymphoma in China
1个月前
已完结
High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party
1个月前
已完结
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition
1个月前
已完结
Mitoxantrone-induced immunosuppression in patients with acute nonlymphocytic leukemia: profound reduction in CD4⁺ T cells and B cells
2个月前
已关闭
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study
2个月前
已完结
R‐THP‐COP versus R‐CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open‐label, noninferiority phase 3 trial
3个月前
已完结
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study
3个月前
已完结
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
4个月前
已完结
CAR-T免疫细胞疗法在抗病毒感染中的研究进展
皖公网安备34019202002308
